Clinical utility of circulating tumor-derived endothelial cells in lung cancer detection and prognosis prediction
Circulating tumor-derived endothelial cells (CTEC) have emerged as promising biomarkers reflecting tumor angiogenesis, disease progression and therapeutic response, although their clinical relevance in lung cancer remains underexplored. A total of 74 patients with lung cancer were enrolled in the present study, and bot...